Recent Data Shows Spending on Legal Cannabis Products Continues to Accelerate

Tuesday, March 13, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+ News Commentary

NEW YORK, March 13, 2018 /PRNewswire/ --

According to a recent report

published by Arcview Market Research, in partnership with BDS Analytics, worldwide spending on legal cannabis is expected to reach $57 billion by 2027. While spending in adult-use cannabis market is expected to reach
$38.3 billion
. North America is projected to dominate in legal cannabis market due to accelerating pace of legalization for both medical and recreational cannabis. The spending in North American is expected to grow from $9.2 billion in 2017 to $47.3 billion in 2027, with a compound annual growth rate of 18 percent during the forecast year. Global Payout, Inc. (OTC: GOHE), Novus Acquisition & Development Corp. (OTC: NDEV), Golden Leaf Holdings Ltd. (OTC: GLDFF), Helix TCS, Inc. (OTC: HLIX), MPX Bioceutical Corporation (OTC: MPXEF)

According to Benzinga, Viridian Capital President Scott Greiper explained that the cannabis industry received $1.23 billion investments in the first five weeks of 2018, up from $178 million a year earlier. Viridian Capital Advisors' Vice President Harrison Phillips said: "Investments in cultivation and retail this year have been driven predominantly by the Canadian player. This has been happening pretty consistently from late 2016 through 2017. This reflects the necessity to scale cannabis businesses, to get some kind of advantage, and to explore strategic opportunities, both through acquisitions and international expansion."

Global Payout, Inc. (OTC: GOHE) on March 8th announced breaking news that, "its subsidiary MoneyTrac Technology, Inc. ("MTRAC", the "Company") is launching a Regulation D 506(c) offering that will be centered around the Company's MTRAC-Token™. The Company plans to use this new token to accomplish its goal of "Banking the UnbankableTM". This press release is not being used for the purpose of solicitating the market for any of the securities offered (see disclaimer below).

The launch of the raise and MTRAC-Token is both the culmination of months spent building crucial relationships and marks the beginning of something much larger for the Company. MTRAC views itself as a "New Age Technology Holding Company," through its network of partnerships and affiliate clients, pioneering a course in the cannabis industry into what has been dubbed the "New Gold Rush." As the cannabis industry currently faces the challenges with banking accessibility and electronic payment solution availability, MTRAC intends to utilize this raise as the resource needed to deliver the solutions they have been co-developing to this rapidly growing industry. With this opportunity MTRAC will work to address some of the industry's biggest challenges by facing them head on and introducing "The New Age of Currency"

Said MTRAC CEO, Vanessa Luna: "The MTRAC-Token™ is a unique type of investment opportunity providing investors a way to be involved in revolutionizing a multitude of industries. Our singular focus over the past several months has been meticulously piecing together our powerful network of partners, which combines two of the most influential and newly successful industries of our generation, cannabis and blockchain technology. We at MoneyTrac are a team of innovators working to develop and introduce the solutions necessary to give businesses operating in the legal cannabis sector the specific tools needed to flourish. There has never been a time like the present, when technology and finance converge to create viable, and much needed, solutions in a burgeoning new industry, which is expected to grow exponentially over the next few years. This is the opportunity this is The MTRAC-Token™"”

Novus Acquisition & Development Corp. (OTC: NDEV), through its wholly-owned subsidiary WCIG Insurance Services, Inc., is a diversified insurance entity in health, liability, annuity and accident, and, the nation's first carrier/aggregator offering a cannabis health plan. On February 12, 2018, the company announced expansion of health benefits packages to Novus Cannabis MedPlan. Coming in March 2018, Novus Cannabis MedPlan will expand cannabis health packages to further position cannabis health insurance in mainstream healthcare. All benefit packages were designed to be competitively priced to other healthcare insurance carriers, giving our patient/members 50%-65% cost reduction on traditional out-of-pocket medical expenses.

Golden Leaf Holdings Ltd. (OTCQB: GLDFF), a Canadian company with operations in multiple jurisdictions including Oregon, Nevada and Canada, is one of the largest cannabis oil and solution providers in North America, and a leading cannabis products company built around recognized brands. Recently, the company announced the availability of new edible product line of cannabis infused fruit chews that includes restorative ingredients that inspires wellbeing. Golden, a Portland-based oils and extracts brand within the Golden Leaf portfolio, has developed this new offering in an effort to help its customers to balance life's highs and lows. Featuring a combination of premium cannabis oil, real fruit and restorative ingredients, the new fruit chews line will offer four bold, new flavors for consumers to choose from. The new line will bring more variety to the Golden brand of products and aim to deliver delicious tasting edibles that are vegan-friendly, gluten-free and soy-free for the health-conscious, non-smoking cannabis consumer.

Helix TCS, Inc. (OTCQB: HLIX) is a premier provider of integrated operating environment solutions for the legal cannabis industry.  Helix provides a proprietary software suite and partnership platform to the legal cannabis industry, helping clients manage inventory and supply costs and bespoke monitoring and transport solutions.  Recently, the company had signed a merger agreement with Bio-Tech Medical Software, Inc. dba BioTrackTHC. Both firms will continue to operate independently, but will rationalize common business functions.  Since its founding in 2015, Helix continues to progress towards becoming a market leader in the legal cannabis industry, operating in the security, transportation, and compliance sectors. In 2016, it acquired Cannabase, the industry's oldest electronic wholesale marketplace.  As one of the largest software providers in the legal cannabis industry, BioTrackTHC has secured nine (9) government contracts for its government seed-to-sale traceability software and provides commercial inventory management and point-of-sale solutions to over 2,200 licensed cannabis operations across 29 states and 5 countries.

MPX Bioceutical Corporation (OTCQB: MPXEF), an Ontario corporation, through its wholly owned subsidiaries in the U.S., provides substantial management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannabis enterprises in Arizona operating under the Health for Life (dispensaries) and the award-winning Melting Point Extracts (high-margin concentrates wholesale) brands. Recently, the company announced that the Company, through its wholly-owned U.S. subsidiary CGX Life Sciences Inc., has entered into a definitive limited liability membership interest and asset purchase agreement, dated and effective March 1, 2018 to, acquire 100% of the membership units of ABACA, LLC, Ambary, LLC, Tarmac Manufacturing, LLC and Tower Management Holdings, LLC.  ABACA is a fully-integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act, A.R.S. Title 36, Section 28.1.

Subscribe Now! Watch us report LIVE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For global payout, inc. financial news dissemination and PR services, has been compensated four thousand dollars for financial news dissemination and PR services by cambridge consultants. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit:

For further information: +1-877-601-1879



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store